<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00772330</url>
  </required_header>
  <id_info>
    <org_study_id>INN003</org_study_id>
    <nct_id>NCT00772330</nct_id>
  </id_info>
  <brief_title>Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms</brief_title>
  <official_title>Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InnFocus Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InnFocus Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the safety and performance of the Miami InnFocus Drainage Implant in patients
      suffering from glaucoma that is inadequately controlled on tolerated medical therapy with
      intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in intraocular pressure relative to the pre-operative value</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of device insertion</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken for procedure</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of glaucoma re-operation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual field</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of eye-related supplemental medical therapy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of implant migration</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of implant encapsulation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>MIDI Arrow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ab externo glaucoma drainage device with no reservoir</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glaucoma Drainage Device</intervention_name>
    <description>Insertion of MIDI Arrow subconjunctivally with a fornix-based incision after pretreatment of scleral surface with 0.4 mg/mL MMC and insertion of MIDI Arrow tube through sclera into anterior chamber of eye</description>
    <arm_group_label>MIDI Arrow</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, age 18 to 85 years, inclusive

          -  Glaucoma that is inadequately controlled on tolerated medical therapy with intraocular
             pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg.

          -  Patient must have signed informed consent form

        Exclusion Criteria:

          -  Unwilling or unable to give informed consent or unable to return for scheduled
             protocol visits

          -  Pregnant or nursing women

          -  No light perception

          -  Active iris neovascularization or active proliferative retinopathy

          -  Iridocorneal endothelial syndrome

          -  Epithelial or fibrous downgrowth

          -  Aphakia (without pseudophakia)

          -  Vitreous in anterior chamber for which a vitrectomy is anticipated

          -  Chronic or recurrent uveitis

          -  Severe posterior blepharitis

          -  Unwilling to discontinue contact lens use after surgery

          -  Previous ophthalmic surgery, excluding uncomplicated phacoemulsification (cataract)
             surgery or corneal refractive surgery

          -  Need for glaucoma surgery combined with other ocular procedures other than cataract
             surgery (i.e., penetrating keratoplasty or retinal surgery) or anticipated need for
             additional ocular surgery

          -  Known allergy to Mitomycin C (MMC) drug.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan F Batlle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laser Center, Santo Domingo, Dominican Republic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laser Center</name>
      <address>
        <city>Santo Domingo</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Dominican Republic</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2008</study_first_submitted>
  <study_first_submitted_qc>October 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2008</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MIDI Arrow</keyword>
  <keyword>Glaucoma Drainage Device</keyword>
  <keyword>GDD</keyword>
  <keyword>InnFocus</keyword>
  <keyword>Glaucoma treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

